Works by Sonneveld, Pieter


Results: 155
    1
    2
    3

    Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.

    Published in:
    Cancers, 2019, v. 11, n. 11, p. 1735, doi. 10.3390/cancers11111735
    By:
    • Bonello, Francesca;
    • Pulini, Stefano;
    • Ballanti, Stelvio;
    • Gentile, Massimo;
    • Spada, Stefano;
    • Annibali, Ombretta;
    • Omedé, Paola;
    • Ronconi, Sonia;
    • Cangialosi, Clotilde;
    • Podda, Luigi;
    • Palmas, Angelo;
    • Malfitano, Alessandra;
    • Rivoli, Giulia;
    • Belotti, Angelo;
    • Ciambelli, Fabrizio;
    • Vincelli, Iolanda Donatella;
    • Cafro, Anna Maria;
    • Innao, Vanessa;
    • Palumbo, Antonio;
    • Sonneveld, Pieter
    Publication type:
    Article
    4
    5
    6
    7

    European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses.

    Published in:
    Oncologist, 2012, v. 17, n. 5, p. 592, doi. 10.1634/theoncologist.2011-0391
    By:
    • LUDWIG, HEINZ;
    • AVET-LOISEAU, HERV;
    • BLAD, JOAN;
    • BOCCADORO, MARIO;
    • CAVENAGH, JAMIE;
    • CAVO, MICHELE;
    • DAVIES, FAITH;
    • DE LA RUBIA, JAVIER;
    • DELIMPASI, SOSANA;
    • DIMOPOULOS, MELETIOS;
    • DRACH, JOHANNES;
    • EINSELE, HERMANN;
    • FACON, THIERRY;
    • GOLDSCHMIDT, HARTMUT;
    • HESS, URS;
    • MELLQVIST, ULF-HENRIK;
    • MOREAU, PHILIPPE;
    • SAN-MIGUEL, JESéS;
    • SONDERGELD, PIA;
    • SONNEVELD, PIETER
    Publication type:
    Article
    8

    The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00789-8
    By:
    • Palladini, Giovanni;
    • Schönland, Stefan;
    • Merlini, Giampaolo;
    • Milani, Paolo;
    • Jaccard, Arnaud;
    • Bridoux, Frank;
    • Dimopoulos, Meletios A.;
    • Ravichandran, Sriram;
    • Hegenbart, Ute;
    • Roeloffzen, Wilfried;
    • Cibeira, M. Teresa;
    • Agis, Hermine;
    • Minnema, Monique C.;
    • Bergantim, Rui;
    • Hájek, Roman;
    • João, Cristina;
    • Leonidakis, Alexandros;
    • Cheliotis, Giorgos;
    • Sonneveld, Pieter;
    • Kastritis, Efstathios
    Publication type:
    Article
    9
    10

    Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
    By:
    • Fernández de Larrea, Carlos;
    • Kyle, Robert;
    • Rosiñol, Laura;
    • Paiva, Bruno;
    • Engelhardt, Monika;
    • Usmani, Saad;
    • Caers, Jo;
    • Gonsalves, Wilson;
    • Schjesvold, Fredrik;
    • Merlini, Giampaolo;
    • Lentzch, Suzanne;
    • Ocio, Enrique;
    • Garderet, Laurent;
    • Moreau, Philippe;
    • Sonneveld, Pieter;
    • Badros, Ashraf;
    • Gahrton, Gösta;
    • Goldschmidt, Hartmut;
    • Tuchman, Sascha;
    • Einsele, Hermann
    Publication type:
    Article
    11
    12

    Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00390-3
    By:
    • Baertsch, Marc-Andrea;
    • Mai, Elias K.;
    • Hielscher, Thomas;
    • Bertsch, Uta;
    • Salwender, Hans J.;
    • Munder, Markus;
    • Fuhrmann, Stephan;
    • Dührsen, Ulrich;
    • Brossart, Peter;
    • Neben, Kai;
    • Schlenzka, Jana;
    • Kunz, Christina;
    • Raab, Marc S.;
    • Hillengaß, Jens;
    • Jauch, Anna;
    • Seckinger, Anja;
    • Hose, Dirk;
    • Luntz, Steffen;
    • Sonneveld, Pieter;
    • Lokhorst, Henk
    Publication type:
    Article
    13

    Oprozomib in patients with newly diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0232-6
    By:
    • Hari, Parameswaran;
    • Matous, Jeffrey V.;
    • Voorhees, Peter M.;
    • Shain, Kenneth H.;
    • Obreja, Mihaela;
    • Frye, John;
    • Fujii, Hisaki;
    • Jakubowiak, Andrzej J.;
    • Rossi, Davide;
    • Sonneveld, Pieter
    Publication type:
    Article
    14
    15

    The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 3, p. 680, doi. 10.1080/10428194.2019.1675881
    By:
    • Mateos, Maria-Victoria;
    • San-Miguel, Jesus;
    • Goldschmidt, Hartmut;
    • Sonneveld, Pieter;
    • Dimopoulos, Meletios A.;
    • Heeg, Bart;
    • Hashim, Mahmoud;
    • Deraedt, William;
    • Hu, Peter;
    • Lam, Annette;
    • He, Jianming
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01149-w
    By:
    • Richardson, Paul G.;
    • Perrot, Aurore;
    • Mikhael, Joseph;
    • Martin, Thomas;
    • Beksac, Meral;
    • Spicka, Ivan;
    • Capra, Marcelo;
    • D'Agostino, Mattia;
    • Sonneveld, Pieter;
    • Bisht, Kamlesh;
    • Fukao, Taro;
    • Zhang, Rick;
    • Tada, Keisuke;
    • Tekle, Christina;
    • Macé, Sandrine;
    • Klippel, Zandra;
    • van de Velde, Helgi;
    • Moreau, Philippe
    Publication type:
    Article
    25
    26

    Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    27

    Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    28
    29

    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 687, doi. 10.1016/j.clml.2023.05.004
    By:
    • Sonneveld, Pieter;
    • Richardson, Paul G.;
    • Ludwig, Heinz;
    • Dimopoulos, Meletios-Athanasios;
    • Schjesvold, Fredrik H.;
    • Hajek, Roman;
    • Abdulhaq, Haifaa;
    • Thuresson, Marcus;
    • Norin, Stefan;
    • Bakker, Nicolaas A.;
    • Mateos, Maria-Victoria
    Publication type:
    Article
    30
    31
    32
    33
    34

    OAB-008: Identification of high-risk Multiple Myeloma with a plasma cell Leukemia-like transcriptomic profile.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02082-6
    By:
    • Bruinink, Davine Hofste op;
    • Kuiper, Rowan;
    • Duin, Mark van;
    • Cupedo, Tom;
    • Velden, Vincent H.J. van der;
    • Hoogenboezem, Remco;
    • Holt, Bronno van der;
    • Beverloo, H. Berna;
    • Valent, Erik T.;
    • Vermeulen, Michael;
    • Gay, Francesca;
    • Broijl, Annemiek;
    • Avet-Loiseau, Hervé;
    • Munshi, Nikhil C.;
    • Musto, Pellegrino;
    • Moreau, Philippe;
    • Zweegman, Sonja;
    • Donk, Niels W.C.J. van de;
    • Sonneveld, Pieter
    Publication type:
    Article
    35
    36

    Pomalidomide and Dexamethasone Treatment for ≥ 1 Year in Renally Impaired Patients With Relapsed or Refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e284, doi. 10.1016/j.clml.2019.09.468
    By:
    • Weisel, Katja;
    • Dimopoulos, Meletios A.;
    • Cook, Mark;
    • Ramasamy, Karthik;
    • Rubia, Javier De La;
    • Ardizzoia, Antonio;
    • Krauth, Maria Theresa;
    • JACCARD, Arnaud;
    • Van de Donk, Niels;
    • Kueenburg, Elisabeth;
    • Di Micco, Antonia;
    • Rosettani, Barbara;
    • Atiba-Davies, Margaret;
    • Bacon, Pamela;
    • Sonneveld, Pieter
    Publication type:
    Article
    37

    Carfilzomib, bendamustine, dexamethasone in patients with advanced multiple myeloma: The EMN09 Phase I/II study of the European Myeloma Network.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e256, doi. 10.1016/j.clml.2019.09.424
    By:
    • Gramatzki, Martin;
    • Offidani, Massimo;
    • Günther, Andreas;
    • Engelhardt, Monika;
    • Salvini, Marco;
    • Montefusco, Vittorio;
    • Patriarca, Francesca;
    • Angelucci, Emanuele;
    • Poenisch, Wolfram;
    • Spada, Stefano;
    • Schub, Natalie;
    • Gentili, Silvia;
    • Wäsch, Ralph;
    • Corradini, Paolo;
    • Einsele, Hermann;
    • Boccadoro, Mario;
    • Sonneveld, Pieter;
    • Gay, Francesca
    Publication type:
    Article
    38
    39

    A Matching-adjusted Indirect Comparison (MAIC) of Bortezomib-Thalidomide-Dexamethasone (VTd) and Daratumumab Plus VTd (D-VTd) Versus Bortezomib-Cyclophosphamide- Dexamethasone (VCd) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) who are Transplant Eligible (TE)

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e201, doi. 10.1016/j.clml.2019.09.335
    By:
    • Sonneveld, Pieter;
    • Dejoie, Thomas;
    • Zweegman, Sonja;
    • Merz, Maximilian;
    • Weisel, Katja;
    • Lam, Annette;
    • Krotneva, Stanimira;
    • Proskorovsky, Irina;
    • Kampfenkel, Tobias;
    • de Boer, Carla;
    • Cote, Sarah;
    • Moreau, Philippe
    Publication type:
    Article
    40

    A Matching-adjusted Indirect Comparison (MAIC) of Bortezomib-Thalidomide-Dexamethasone (VTd) and Daratumumab Plus VTd (D-VTd) Versus Bortezomib-Dexamethasone (Vd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) who are Transplant Eligible (TE).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e200, doi. 10.1016/j.clml.2019.09.334
    By:
    • Moreau, Philippe;
    • Attal, Michel;
    • Facon, Thierry;
    • Caillot, Denis;
    • LENAIN, Pascal;
    • Benboubker, Lofti;
    • Lam, Annette;
    • Krotneva, Stanimira;
    • Proskorovsky, Irina;
    • Kampfenkel, Tobias;
    • Vanquickelberghe, Véronique;
    • Cote, Sarah;
    • Sonneveld, Pieter
    Publication type:
    Article
    41

    A Matching-Adjusted Indirect Comparison (MAIC) of Daratumumab-Bortezomib-Thalidomide-Dexamethasone (D-VTd) Versus Bortezomib-Lenalidomide-Dexamethasone (VRd) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (NDMM) who are Transplant Eligible.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e199, doi. 10.1016/j.clml.2019.09.333
    By:
    • Moreau, Philippe;
    • Attal, Michel;
    • Facon, Thierry;
    • Leleu, Xavier;
    • Hulin, Cyrille;
    • Hashim, Mahmoud;
    • Hu, Yannan;
    • Cote, Sarah;
    • Kampfenkel, Tobias;
    • de Boer, Carla;
    • Lam, Annette;
    • Sonneveld, Pieter
    Publication type:
    Article
    42
    43
    44
    45
    46

    Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trials.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e43, doi. 10.1016/j.clml.2019.09.065
    By:
    • Mai, Elias K.;
    • Baertsch, Marc-A.;
    • Hielscher, Thomas;
    • Bertsch, Uta;
    • Schlenzka, Jana;
    • Salwender, Hans J.;
    • Munder, Markus;
    • Fuhrmann, Stephan;
    • Duehrsen, Ulrich;
    • Brossart, Peter;
    • Neben, Kai;
    • Raab, Marc S.;
    • Jauch, Anna;
    • Seckinger, Anja;
    • Hose, Dirk;
    • Luntz, Steffen;
    • Sonneveld, Pieter;
    • Lokhorst, Henk;
    • Martin, Hans;
    • Lindemann, Hans-Walter
    Publication type:
    Article
    47

    Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e32, doi. 10.1016/j.clml.2019.09.048
    By:
    • Dimopoulos, Meletios A.;
    • Weisel, Katja;
    • Moreau, Philippe;
    • Anderson, Larry D.;
    • White, Darrell;
    • San-Miguel, Jesus;
    • Sonneveld, Pieter;
    • Engelhardt, Monika;
    • Jenner, Matthew;
    • Corso, Alessandro;
    • Dürig, Jan;
    • Pavic, Michel;
    • Salomo, Morten;
    • Casalz, Eva;
    • Jiang, Ruiyun;
    • Srinivasan, Shankar;
    • Nguyen, Tuong Vi;
    • Bensmaine, Amine;
    • Peluso, Teresa;
    • Richardson, Paul G.
    Publication type:
    Article
    48

    Prognostic and Predictive Performance of SKY92 Combined with R-ISS in Elderly Multiple Myeloma Patients in The Hovon-87/NMSG-18 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e10, doi. 10.1016/j.clml.2019.09.014
    By:
    • Kuiper, Rowan;
    • Broijl, Annemiek;
    • van Duin, Mark;
    • van Vliet, Martin H.;
    • Levin, Mark-David;
    • van Beers, Erik H.;
    • Van der Holt, Bronno;
    • Visser, Heleen;
    • Hansson, Markus;
    • van der Velden, Annette W.G.;
    • Dumee, Belinda;
    • Vermeulen, Michael;
    • Koenders, Jasper;
    • Beverloo, H. Berna;
    • Stevens-Kroef, Marian;
    • Sonneveld, Pieter;
    • Waage, Anders;
    • Zweegman, Sonja
    Publication type:
    Article
    49

    Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.004
    By:
    • Sonneveld, Pieter;
    • Attal, Michel;
    • Perrot, Aurore;
    • Hulin, Cyrille;
    • Caillot, Denis;
    • Facon, Thierry;
    • Leleu, Xavier;
    • Belhadj-Merzoug, Karim;
    • Karlin, Lionel;
    • Benboubker, Lofti;
    • Levin, Mark-David;
    • Minnema, Monique;
    • Westerman, Matthijs;
    • Delforge, Michel;
    • Zweegman, Sonja;
    • Pei, Lixia;
    • de Boer, Carla;
    • Vanquickelberghe, Véronique;
    • Kampfenkel, Tobias;
    • Moreau, Philippe
    Publication type:
    Article
    50

    Heavy+Light Chain and Free Light Chain Assays at Baseline and During Follow-up in EMN02/HO95 Multiple Myeloma Clinical Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e47, doi. 10.1016/j.clml.2017.03.084
    By:
    • Omedè, Paola;
    • Redoglia, Valter;
    • Astolfi, Monica;
    • Larocca, Alessandra;
    • Spada, Stefano;
    • Bourlot, Luigi;
    • Cavo, Michele;
    • Petrucci, Maria Teresa;
    • Di Raimondo, Francesco;
    • Patriarca, Francesca;
    • Rambaldi, Alessandro;
    • Rossi, Giuseppe;
    • Ballanti, Stelvio;
    • Gamberi, Barbara;
    • Vincelli, Iolanda Donatella;
    • Grasso, Mariella;
    • Liberati, Anna Marina;
    • Corradini, Paolo;
    • Sonneveld, Pieter;
    • Boccadoro, Mario
    Publication type:
    Article